Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
作者： Isidoro Di Carlo , Elia Pulvirenti , Francesca Sparatore , Adriana Toro , Stefano Cordio
DOI: 10.1016/J.SURONC.2007.10.027
关键词:
摘要: Peritoneal carcinomatosis (PC), a malignancy limited to the peritoneal surface, has severe prognosis, but new therapeutic approach resulted in cure some cases. The treatment consists of complete cytoreductive surgery combination with hyperthermic intraperitoneal chemotherapy or early postoperative chemotherapy. At present, only about 25 centers United States offer this treatment, and few have treated more than 100 This may be most promising therapy for PC from colorectal cancer requires collaboration among medical oncologists, surgeons, surface centers.
elsevier.com
sci-hub.se 参考文章(14)
Tristan D. Yan, Matthew Links, Sal Fransi, Theresa Jacques, Deborah Black, Vanessa Saunders, David L. Morris, Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy—A Journey to Becoming a Nationally Funded Peritonectomy Center Annals of Surgical Oncology. ,vol. 14, pp. 2270- 2280 ,(2007) , 10.1245/S10434-007-9406-8
Dominique Elias, Diane Goere, François Blot, Valérie Billard, Marc Pocard, Niaz Kohneh-Shahri, Bruno Raynard, Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43°C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients Annals of Surgical Oncology. ,vol. 14, pp. 1818- 1824 ,(2007) , 10.1245/S10434-007-9348-1
Tristan D. Yan, Junyang Sim, David L. Morris, Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Annals of Surgical Oncology. ,vol. 14, pp. 1807- 1817 ,(2007) , 10.1245/S10434-007-9350-7
P. H. Sugarbaker, Management of peritoneal-surface malignancy: the surgeon’s role Langenbeck's Archives of Surgery. ,vol. 384, pp. 576- 587 ,(1999) , 10.1007/S004230050246
Babak Sadeghi, Catherine Arvieux, Olivier Glehen, Annie C Beaujard, Michel Rivoire, Jacques Baulieux, Eric Fontaumard, Alain Brachet, Jean L Caillot, Jean L Faure, Jack Porcheron, Jean L Peix, Yves François, Jacques Vignal, François N Gilly, None, Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. ,vol. 88, pp. 358- 363 ,(2000) , 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
Paul H. Sugarbaker, Successful management of microscopic residual disease in large bowel cancer Cancer Chemotherapy and Pharmacology. ,vol. 43, ,(1999) , 10.1007/S002800051093
Dominique Elias, Emmanuel Benizri, Daniela Di Pietrantonio, Paola Menegon, David Malka, Bruno Raynard, Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis Annals of Surgical Oncology. ,vol. 14, pp. 509- 514 ,(2007) , 10.1245/S10434-006-9167-9
Tristan D. Yan, Lana Bijelic, Paul H. Sugarbaker, Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms Annals of Surgical Oncology. ,vol. 14, pp. 2289- 2299 ,(2007) , 10.1245/S10434-007-9462-0
DP Korkolis, Ch Aggeli, I Passas, G Plataniotis, Peritoneal carcinomatosis from colorectal cancer British Journal of Surgery. ,vol. 89, pp. 1545- 1550 ,(2002) , 10.1046/J.1365-2168.2002.02274.X
David ZJ Chu, Nicholas P Lang, Carolyn Thompson, Paul K Osteen, Kent C Westbrook, None, Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer. ,vol. 63, pp. 364- 367 ,(1989) , 10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V